PRMT3-介导的H4R3me2a通过驱动神经元中的高酸化来促进与年龄相关的初级陶病症
Haotian Liu1,2, Xinnan Liu2, Fengyuan Tian1
1Department of Immunology, State Key Laboratory of Complex, Severe, and Rare Diseases, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, 100005, China.
概括
研究人员确定了蛋白质氨酸甲基转移酶3 (PRMT3) 作为初级年龄相关陶病 (PART) 中陶过酸化的关键驱动因素. 抑制PRMT3显示了对PART和其他病的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 主要与年龄相关的陶病 (PART) 和阿尔茨海默氏症 (AD) 在海马体-内腔系统中共享陶病理.
- 与AD相比,PART在内腔皮层 (EC) 中表现出更大的陶过化,其潜在机制尚不清楚.
- 了解Aβ独立的高酸化对于开发向的PART疗法至关重要.
研究的目的:
- 在PART.中识别高酸化的分子驱动因素.
- 阐明Aβ独立的高酸化的机制性途径.
- 评估PRMT3抑制作为治疗病的治疗策略.
主要方法:
- 尸体 EC 组织的转录形状分析.
- 鉴定目标的体外和体外功能验证.
- 对选择性PRMT3抑制剂 (SGC707) 降低陶过酸化的评估.
主要成果:
- 蛋白质氨酸甲基转移酶3 (PRMT3) 被确定为陶过酸化的关键驱动因素.
- PRMT3通过H4R3me2a调节miR-448,抑制IGF1R,激活GSK3β并促进的过酸化.
- 在实验模型中,SGC707治疗显著降低了的过酸化.
结论:
- PRMT3/H4R3me2a/miR-448轴是PART tau过酸化的一个关键调节途径.
- 抑制PRMT3为PART和其他病症提供了一个有前途的治疗途径.
- 准PRMT3为管理神经退行性病症提供了一种新的策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Enzyme-linked Receptors
76.1K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.1K


